Sanara MedTech Inc. (NASDAQ: SMTI) reported Q2 EPS of ($0.05), $0.02 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $28.14 million versus the consensus estimate of $28.95 million.

For earnings history and earnings-related data on Sanara MedTech Inc. (SMTI) click here.